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Summary It was hypothesised that one may be able to visualise field changes, which are proposed to exist
around tumours, as alterations in keratin intermediate filament protein expression. Standard immunohisto-
chemical analysis using a panel of monoclonal anti-keratin antibodies was applied to fresh tissue sections to
look for subtle changes in epithelial differentiation not visible in H&E sections. Such changes were observed in
clinically normal epithelium from oral cancer patients, involving primarily substantial expression of keratins
K8/K7 (using CAM 5.2) in the basal cells of 12 out of 34 biopsies, and also a trend towards a reduction in the
complexity of keratin differentiation. Monitoring such changes may prove to be a valuable adjunct to
conventional H&E staining if found to have prognostic and diagnostic significance.
The concept of field cancerisation, first proposed by Slaugh-
ter et al. in 1953, has frequently been quoted to explain the
occurrence of multiple primary cancers in the head and neck
region and recurrence following complete excision of the
original tumour. The adverse influence that these second
malignant tumours (SMT's) may have on such patients has
been reviewed elsewhere (Ogden, 1991). Virtually all reports
concerned with SMT's attribute this to the effect of alcohol
and tobacco (Strong et al., 1984; Lippman & Hong, 1989).
Interestingly when Slaughter et al. (1953) published their
hypothesis they were not aware of any particular aetiological
factor for oral cancer. However it should not be forgotten
that SMT's can also occur in those who have never smoked
or taken alcohol, as well as in those who gave up both habits
after diagnosis of the initial tumour (Wynder et al., 1969).
Whereas in the latter SMT's may occur due to previous
damage caused by the alcohol or tobacco, this does not
explain why SMT's occur in the former group. Thus the
disease process itself is likely to exert a regional effect upon
thee mucosa of head and neck cancer patients. Throughout
the following text the term tumour refers to malignant
tumours only.
Although Slaughter's paper (1953) is frequently quoted to
support the concept of field change, little evidence exists to
confirm it. Slaughter's original work in 1946 was based upon
his finding satellites of dysplastic looking epithelium away
from the main bulk of the lesion.
Incze et al. (1982) found evidence at an ultrastructural
level for premalignancy in normal oral mucosa remote from
head and neck tumours. Namely an increase in nuclear area
and altered nuclear to cytoplasmic area ratio. Despite both
groups of patients smoking, they concluded that the changes
observed were probably related to tobacco use. However, no
account was taken of alcohol intake, a frequent co-factor in
such patients. Furthermore, examination of nuclear and
cytoplasmic area is more reliable by light microscopy than
electron microscopy.
More recent evidence for field change has come from
studies utilising exfoliative cytology. We have reported a
reduction in cytoplasmic area (CA) for normal buccal mucosa
in patients with malignant disease both distant from and
within the oral cavity, compared with cancer free patients
(Ogden et al., 1990). Although such changes may be a
marker for internal malignancy the influence of general
debilitation could not be excluded as a contributory fac-
tor.
A similar technique was employed to look for evidence of
field change in oral cancer patients. A reduction in CA for
normal buccal mucosa was found for the oral cancer group,
compared to the cancer free group (Ogden et al., 1990). That
this was indeed significant derives from the fact that other
factors that could have influenced such results, e.g., anaemia,
inflammation and radiotherapy were excluded. Furthermore,
this reduction in CA (which mirrors that seen in smears
(Cowpe et al., 1990) and biopsies (Wright & Shear, 1985)
from lesions that later become malignant) occurred irrespec-
tive of the use of either alcohol or tobacco (Ogden et al.,
1991). However, such 'field change' did not result in aberrant
DNA profiles (Ogden et al., 1991).
The concept of field cancerisation perhaps more appropri-
ately now termed 'field transformation' is an attractive one
particularly when trying to explain the occurrence of another
tumour following complete excision of the original lesion.
That the tumour itself exercises a regional effect on the oral
mucosa appears possible, in spite of histopathological
confirmation that the margins of an excised tumour are clear.
Changes associated with field cancerisation by their very
nature, may be expected to be subtle. The identification of a
marker present in malignant cells, but absent from non neo-
plastic cells if found in 'normal' oral mucosa of oral cancer
patients would be strongly suggestive of a field change.
Much attention has recently focused upon the keratin
cytoskeleton (Cooper et al., 1985; Lane & Alexander, 1990)
in tumour diagnosis. Keratins are the intermediate filament
proteins found within the cytoplasm of all epithelial cells.
There are at least 20 different keratin polypeptides whose
expression alters with the state of tissue differentiation. The
identification of specific keratins in normal oral mucosa of oral
cancer patients may indicate subtle changes in cellular mor-
phology that are not apparent in routine H & E sections.
Thus, the aims of this paper are to examine the evidence of
field change in tissue sections of normal oral mucosa from
oral cancer patients and compare the findings to cancer free
patients using immunohistochemistry to identify changes in
cytokeratin expression.
Materials and methods
Biopsies were obtained of clinically normal oral mucosa
removed from the wound margin that was left following
excision of the malignant tumour. Sometimes tissue from
more than one site was obtained. In each case the tumour
had been confirmed as a squamous cell carcinoma following
routine histopathological examination. The malignant lesions
were always excised with at least a 1 cm margin of clinically
normal oral mucosa. Ethics committee approval had been
granted by the Tayside Medical Ethics Committee.
Normal oral mucosa from non cancer patients was
obtained either as redundant tissue (e.g. exposure of an
unerupted canine tooth), part of the excision of a benign
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condition (e.g. ranula), to allay the fears of those with
psychosomatic disorders (e.g. burning mouth syndrome) or
voluntary submission of a willing donor (i.e. research col-
league).
Both sets of biopsies were frozen immediately in liquid
nitrogen/isopentane or transported from a nearby hospital in
Carmichael's medium (Ogden et al., 1992) prior to storage in
liquid nitrogen. H & E stained sections were obtained for
each biopsy.
When required the tissue blocks were removed from liquid
nitrogen, 5pm sections cut and then fixed in acetone for
5 min.
For cytokeratin assessment a panel of antikeratin
antibodies were applied for one hour at room temperature,
diluted in phosphate buffered saline (PBS) (0.05 M,
pH 7.4).
The following antibodies were used, with keratin
specificities in parentheses and dilutions in square brackets:
LP34 (K5, K6, K18) [1 in 10]; AE8 (K13) [1 in 50]; LP2K
(K19) [1 in 5]; LHI (KIO) [undiluted]; CAM5.2 (K7, K8)
[undiluted]. CAM 5.2 is often cited as recognising keratins 8,
18 and 19 (Makin et al., 1984) but its major specificity is for
K8, with some K7 reactivity (Smedts et al., 1990). Normal
goat serum acted as the negative control and LP34 the
positive control (since it identifies a set of keratins that are
represented in all epithelial cells).
A standard protocol was followed, using the avidin biotin
complex technique (Vectastain, Vector Labs, Peterborough,
England). Briefly, following incubation with the primary
antibody, the sections were rinsed in PBS and then the link
antibody (biotinylated anti-mouse immunoglobin - BAMG)
applied for 30 min, at room temperature. The sections were
then rinsed with PBS prior to applying the avidin-biotin
complex. This consists of avidin together with biotinylated
horseradish peroxidase which is allowed to complex for
30 min prior to its application to the tissue section for
30 min, at room temperature. Sections were once again rinsed
with PBS prior to addition of the substrate for the
horseradish peroxidase enzyme. This consisted of
diaminobenzidine tetrahydrochloride (DAB, 5 mg in 10 ml
PBS) freshly filtered and mixed with hydrogen peroxide (5 ml
of 30 vols) which was applied for 5 to 10 min at room
temperature. Sections were again washed in PBS prior to the
application of a counterstain (namely immersion in Mayers
haematoxylin for 15 to 30 s) and then washing in Scott's tap
water substitute. The corresponding tumours were treated in
a similar manner for keratin expression.
Results
Examination of H & E stained sections revealed that the
morphology of most biopsies was within the limits of normal
variation in normal mucosa. Occasionally mild basal cell
hyperplasia and acanthosis were observed. All were con-
sidered free of tumour.
Keratin cytoskeleton
'Normal' oral mucosa was obtained from 34 patients with
oral cancer and 20 patients with no history of oral cancer
and no obvious oral mucosal abnormality. Table I describes
the extent of expression of each keratin studied in terms of
basal (B) cell and suprabasal (S) cell expression. In addition
smoking and alcohol habits are detailed (where known).
The following keratin profiles were confirmed in normal
oral mucosa from non cancer patients (Table II). In 'non
keratinising' sites; basal cell expression of K19, suprabasal
expression of K13 and no expression of K8/K7, or KIO. In
'keratinising' sites: occasional basal cell expression of K19,
occasional suprabasal expression of K13, suprabasal expres-
sion of KIO and no expression of K8.
For the 'normal' mucosa from oral cancer patients staining
with CAM 5.2 occurred in most of the basal cells in 12 of 34
biopsies (example, Figure 1). The associated tumours except
one were also positive to CAM 5.2. This extent of CAM 5.2
positivity never occurred in the non cancer patients except
for the occasional Merkel cell (Table 1).
Keratin 19 was expressed throughout the suprabasal
epithelium in 'non-keratinising' sites in five of 28 biopsies
(e.g. Figure 2) and was also frequently identified in the basal
cells of 'keratinising' sites in 'normal' mucosa from oral
cancer patients. Although the former was not seen in non
cancer patients, the latter was occasionally observed. (Four
of the five with suprabasal K19 expression also had K19
positive tumours). Basal cell expression of K19 was lost in six
cases (Figure 3a) even when the tumours expressed K19
(Figure 3b).
Keratin 13 was identified in all but two of 18 biopsies from
'normal' floor of mouth. In contrast K13 was expressed
throughout the suprabasal cells of these 'non-cornifying' sites
in non cancer patients.
Keratin 10 was expressed throughout the suprabasal region
in one of ten cases from normal buccal mucosa and two of
18 cases from normal floor of mouth (e.g. Figures 4, 5). It is
of interest that in the former the corresponding tumour was
K1O positive but not in the latter case.
The pan-epithelial marker LP34 stained all the epithelial
cells. Table III summarises the staining patterns for normal
oral mucosa from oral cancer and non cancer patients.
Discussion
When Slaughter et al. (1953) first discussed the concept of
field change they referred to a multicentric origin for oral
cancer. Examination of tissue removed from around the
clinically obvious lesion revealed histomorphological evidence
for dysplasia and the change termed field cancerisation. It is
worth noting that partly as a consequence of their findings,
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Figure 1 Expression of keratin 8/7 (CAM 5.2) in the basal cells
of 'normal' buccal mucosa (x 140).1326 G.R. OGDEN et al.
Table I Keratin expression for biopsies of 'normal' mucosa for each oral cancer patient
K8, K7 K19
Pt. Age Sex Site Smoke Alcohol B S B S
1 69 F NVT - - (+) + +
LesVt
2 62 M NBM
LesPal
3 84 F NBM
LesBM
4 85 F NFOM
LesVT
5 54 M NBM
LesAlv
6 81 F NMB
LesBM
7 71 M NVT
LesVT
8 64 M NPal
LesPal
9 32 F NVT
LesVT
10 76 F NB
LesBM
11 72 M NFOM
LesLatT
12 59 M NBM
LesPal
13 71 M NBM
LesBM
14 57 M NSPal
LesPal
15 86 F NFOM
LesFOM
16 72 M NMB
LesPal
17 84 F NFOM
LesFOM
18 56 F NFOM
LesFOM
19 58 M NFOM
LesFOM
20 72 M NVT
LesVT
21 80 M NFOM
LesFOM
22 55 M NVT
NBM
LesVT
23 83 F NPal
LesPal
24 74 M NFOM
LesFOM
25 71 M NSPal
LesAlv
26 53 F NFOM
LesFOM
27 61 F NVT
LesVT
28 75 F NBM
LesBM
29 62 M NFOM
LesFOM
30 75 M NVT
LesFOM
NBM
31 76 M NMB
LesPal
32 73 M NFOM
LesFOM
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Age (years); Sex: M = Male, F = Female; Site: N = Normal; VT = Ventral tongue, Lat = Lateral tongue,
FOM = Floor of mouth; BM = Buccal mucosa, Pal = Palate, Alv = Alveolus; Smoke/Alcohol: Y = Yes
(Y) = formerly, N = No, - = Unknown; Keratin (K) identified in: B = Basal cells, S = Supbrabasal cells:
+ = most cells positive, (+) = few cells positive, blank = absent. CAM 5.2: see Methods.FIELD CHANGE IN ORAL CANCER 1327
Table II Assessment of keratin expression in normal oral mucosal
biopsies from non-cancer patients
Positive K8, K7 KJO K19 K13
B S B S B S B S B S
NDT + + (+) - - - + (+) - +
NDT + + (+) - - - + _ - +
NDT + + (+) - - (+) + - - +
NDT + + (+) - - (+) + _ _ +
NDT + + (+) - - (-) + (+) _ +
NPal + + (+) - - (+) (+) -
NPal + + (+) - - + (+) _
NPal + + (+) - - + _ _ _ _
NPal + + (+) - - (+) (+) _
NVT + + - - - - + _ _ +
NVT + + - - - - + _ _ +
NVT + + - - + (+) - +
NBM + + - - - (+) - - - +
NBM + + (+) - - (+) + - - +
NBM + + (+) - - - (+) - - +
NBM + + (+) - - - + - - +
NBM + + + - - - + - - +
NBM + + - - - - + - - +
NBM + + (+) - - (+) + - - +
NBM + + (+) - - - + - - +
B = Basal; S = Suprabasal expression; Keratin present '+', absent
minimally expressed (+).
Table III Summary of keratin staining in clinically normal oral
mucosal biopsies (-: absent; (+): few cells positive; +: most cells
positive)
Epithelial Staining
region pattern K7/K8 KJO K19 K13
Non cancer Basal - 5 20 2 20
patients (+) 14 0 4 0
+ 1 0 14 0
Suprabasal - 20 10 17 1
(+) 0 8 3 3
+ 0 2 0 16
Oral cancer Basal - 13 33 8 33
patients (+) 9 1 5 1
+ 12 0 21 0
Suprabasal - 33 26 22 3
(+) 0 3 6 2
+ 1 5 6 29
Figure 2 Keratin 19 (LP2K) staining
1 cm bar = 62jp.
current surgical practice now leads to a wider excision mar-
gin than practised previously. Thus the findings reported in
the present study of inappropriate cytokeratin expression in
'normal' oral mucosa with no overt histomorphological signs
of malignancy appear supportive of a field change.
Cytokeratin expression
Inappropriate expression ofsimple epithelial keratins Keratins
8/7 (identified by CAM 5.2) were expressed in the basal cells
of approximately a third of the normal biopsies from oral
cancer patients. Keratins 8/K7 are not expressed by normal
oral keratinocytes (Morgan et al., 1987; Sawef et al., 1991)
although occasional staining of Merkel cells in the basal
region has been observed (Morgan et al., 1987). However the
extent of K8/K7 expression in the basal cells reported above,
together with the histomorphological detail was highly sug-
gestive of basal cells expression of K8/K7 in normal oral
mucosa of oral cancer patients. One study using immunoblot-
ting techniques found K8 in basal cells of normal dorsal and
ventral tongue (Clausen et al., 1986) but this may have been
due to 'contamination' by glandular tissue or even Merkel
cells.
Previous reports have suggested that the simple epithelial
keratins (such as K8) are only expressed in poorly
differentiated tumours (Morgan et al., 1987a). We have also
found such expression in a significant number of well
differentiated tumours (Ogden et al., 1993). In so doing such
basal cell expression mirrors that seen in the corresponding
tumours (Morgan et al., 1987a; Ogden et al., 1993).
Further evidence supportive of a field change derives from
the suprabasal expression of K19 in 'normal' buccal mucosa
and floor of mouth region. Significantly such changes occur-
red in those sites most frequently affected by oral cancer
(Mashberg & Samit, 1989). In most cases the corresponding
tumours were also positive. It has been suggested that K19
expression, particularly in those oral sites where it is not
usually seen, is related to inflammation (Bosch et al., 1989).
However we would challenge this since there was little
evidence in most of our cases for profound inflammatory
change. An increase in K19 expression within oral leuko-
plakias has been associated with mucosal instability and
malignant change (Lindberg & Rheinwald, 1989). Since in-
creased expression of K19 was not seen in the non cancer
patients such a profile may herald a propensity tc undergo
malignant change. However, loss of basal cell expression of
throughout the suprabasal epithelium of 'normal' floor of mouth (x 160).1328 G.R. OGDEN et al.
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Figure 3 a, Loss of basal cell expression of K19 (LP2K) in 'normal' floor of mouth (x 140). 1 cm bar = 71 p. b, Decreased basal
cell expression of K19 (LP2K) in epithelium overlying tumour expressing K19 (x 140).
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Figure 4 Suprabasal expression of K1O (LH1) in a biopsy of 'normal' floor of mouth (x 140).
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Figure 5 Suprabasal expression of K10 (LH1) in 'nornal' floor of mouth (x 140).
K19 in 'non-keratinising' sites was also identified, even in the
mucosa above a K19 positive tumour (Figure 3c). Thus the
significance of K19 expression (or lack of it) appears un-
clear.
Reduction of appropriate cytokeratin expression Further
evidence for a field change comes from a reduction in com-
plexity of differentiation. For example, as well as K19 reduc-
tion discussed above complete loss of K13 expression in
'normal' floor of mouth also occurred. A similar loss of K13
in 'normal' mucosa adjacent to a buccal mucosal cancer has
been reported by Vaidya et al. (1989). Interestingly one
patient with loss of K13 expression developed a recurrence
one year later.
In Table I the tobacco and alcohol habits are recorded
where known. Given that other important tumour diagnostic
markers such as p53 can be influenced by smoking habits
(Ogden et al., 1992; Field et al., 1992), the influence of
tobacco on cytokeratin expression could be significant. For
example, although there were approximately equal numbers1330 G.R. OGDEN et al.
of cases that were negative for CAM 5.2 in smokers com-
pared to non-smokers, basal cell staining was much more
frequent in the smoking group. There was no obvious
association of tobacco or alchohol use with the other
keratins studied. Furthermore, altered keratin profiles were
also seen in those who did not smoke or take alcohol. Since
further tumours can arise even in those abstaining from these
high risk aetiological factors, the keratin profiles obtained
offer a sensitive indication of altered tissue differentiation.
Whether these cases of inappropriate keratin expression
are indicative of an increased likelihood of further tumours is
not known, since this study only covers a 3 year period.
The changes in keratin expression reported above should
not however be interepreted as inadequate excision of the
primary lesion until their clinical significance is known. Ac-
cording to a recent review (Shaha et al., 1988) multiple
primary tumours occur in approximately 10% of all head
and neck cancer patients, thus a clinically significant field
change may not always occur.
Classical histopathological diagnosis relies upon the assess-
ment of H & E stained sections to check that the margins are
clear of tumour. The significance of these reported changes in
keratin expression in essentially normal oral mucosa of oral
cancer patients now requires evaluation. They may yet
become a valuable additional test in the diagnostic and prog-
nostic evaluation of patients with oral carcinomas.
This research is supported by the Cunningham Trust and Medical
Research Council.
We thank Ms S. McQueen and Mr R. Kiddie for technical assis-
tance and Mrs Dorothy Morrison for typing the manuscript.
References
BOSCH, F.X., OUHAYOUN, J.P., BERNHARD, L., BADER, B.L., COL-
LIN, C., GRUND, C.I., LEE, I. & FRANKE, W.W. (1989). Extensive
changes in cytokeratins expression patterns in pathologically
affected human gingiva. Virch. Archiv. B. Cell Pathol., 58,
59-77.
CLAUSEN, H., MOE, D., BUSCHARD, K. & DABELSTEEN, E. (1986).
Keratin proteins in human oral mucosa. J. Oral Pathol., 15,
36-42.
COOPER, D., SCHERMER, A., SUN, T.-T. (1985). Classification of
human epithelia and their neoplasms using monoclonal
antibodies to keratins: strategies, applications and limitations.
Lab. Invest., 52, 243-256.
COWPE, J.G., LONGMORE, R.B. & GREEN, M.W. (1988). Quantitative
exfoliative cytology of abnormal oral mucosal smears. J. Roy.
Soc. Med., 81, 509-513.
FIELD, J.K., SPANDIDOS, D.A. & STELL, P.M. (1992). Overexpression
of p53 gene in head and neck cancer linked with heavy smoking
and drinking. Lancet, 339, (8791), 502-503.
INCZE, J., VAUGHAN, C.W., LIU, P., STRONG, M.S. &
KULAPADITHAR, O.M.B. (1982). Premalignant changes in normal
appearing epithelium in patients with squamous cell carcinoma of
the upper aerodigestive tract. Am. J. Surg., 144, 401-405.
LANE, E.B. & ALEXANDER, C.M. (1990). Use of keratin antibodies in
tumour diagnosis. Sem. Cancer Biol., 1, 165-179.
LINDBERG, K. & RHEINWALD, J.G. (1989). Suprabasal 40 kd keratin
(K19) expression as an immunohistologic marker of premalig-
nancy in oral epithelium. Am. J. Pathol., 134, 89-98.
LIPPMAN, S.M. & HONG, W.K. (1989). Second malignant tumours in
head and neck squamous cell carcinoma: the overshadowing
threat of patients with early-stage disease. Int. J. Rad. Oncol.
Biol. Phys., 17, 691-694.
MAKIN, C.A., BOBROW, L.G. & BODMER, W.F. (1984). Monoclonal
antibody to cytokeratin for use in routine histopathology. J. Clin.
Pathol., 37, 975-983.
MASHBERG, A. & SAMIT, A.M. (1989). Early detection, diagnosis and
management of oral and oropharyngeal cancer. CA - a cancer
journal for clinicians, 39, 67-88.
MORGAN, P.R., LEIGH, I.M., PURKIS, P.E., GARDNER, I.D., VAN
MUIJEN, G.N.P. & LANE, E.B. (1987). Site variation in keratin
expression in human oral epithelia - an immunocytochemical
study of individual keratins. Epithelia, 1, 31-43.
MORGAN, P.R., SHIRLAW, P.J., JOHNSON, N.W., LEIGH, I.M. &
LANE, E.B. (1987a). Potential applications of antikeratin
antibodies in oral diagnosis. J. Oral Pathol., 16, 212-222.
OGDEN, G.R., COWPE, J.G. & GREEN, M.W. (1990). The effect of
distant malignancy upon quantitative cytologic assessment of
normal oral mucosa. Cancer, 65, 477-480.
OGDEN, G.R., COWPE, J.G. & GREEN, M.W. (1990). Evidence of field
change in oral cancer. Br. J. Oral Maxillofac. Surg., 28,
390-392.
OGDEN, G.R. (1991). Second malignant tumours in head and neck
cancer. Br. Med. J., 302, 193-194.
OGDEN, G.R., COWPE, J.G. & GREEN, M.W. (1991). Detection of field
change in oral cancer using oral exfoliative cytologic study.
Cancer, 68, 1611-1615.
OGDEN, G.R., NAIRN, A., CARMICHAEL, A., COGHILL, G., CREE,
I.A., GREEN, M.W., HOPWOOD, D.V. & CHISHOLM, D.M. (1992).
Preservation of keratin expression in oral mucosa using a novel
transport medium. J. Oral. Pathol. Med., 21, 17-20.
OGDEN, G.R., KIDDIE, R.A., LUNNY, D.P. & LANE, D.P. (1992).
Assessment of p53 protein expression in normal, benign, and
malignant oral mucosa. J. Pathol., 166, 389-394.
OGDEN, G.R., CHISHOLM, D.M., ADI, M. & LANE, E.B. (xxxx).
Cytokeratin expression in oral cancer and its relationship to
tumour differentiation. J. Oral Pathol Med., (in press).
SAWAF, M.H., OUHAYOUN, J.P. & FOREST, N. (1991). Cytokeratin
profiles in oral epithelia: A review and a new classification. J.
Biol. Buccale, 19, 187-198.
SHAHA, A., HOOVER, E., MARTI, J. & KRESPI, Y. (1988). Is routine
triple endoscopy cost-effective in head and neck cancer? Am. J.
Surg., 155, 750-753.
SLAUGHTER, D.P. (1946). Multicentric origin in intra oral car-
cinoma. Surgery, 20, 133-146.
SLAUGHTER, D.P., SOUTHWICK, H.W. & SMEJKAL, W. (1953). Field
cancerization in oral stratified squamous epithelium. Cancer, 6,
963-968.
SMEDTS, F., RAMAEKERS, F.C.S., ROBBEN, H., PRUSZCYNSKI, M.,
VAN MUIJEN, G., LANE, B., LEIGH, I. & VOOIJS, P. (1990). Chang-
ing patterns of keratin expression during progression of cervical
intraepithelial neoplasia. Am. J. Pathol., 136, 657-668.
STRONG, M.S., INCZE, J. & VAUGHAN, C.W. (1984). Field canceriza-
tion in the aerodigestive tract - its etiology, manifestation and
significance. J. Otolaryngol., 13, 1-6.
VAIDYA, M.M., BORGES, A.M., PRADHAM, S.A., RAJPAL, R.M. &
BHISSEY, A.N. (1989). Altered keratin expression in buccal
mucosal squamous cell carcinoma. J. Oral Pathol. Med., 18,
282-286.
WRIGHT, A. & SHEAR, M. (1985). Epithelial dysplasia immediately
adjacent to oral squamous cell carcinomas. J. Oral Pathol., 14,
559-564.
WYNDER, E.G., DODO, H., BLOCH, D., GRANT, R.C. & MOORE, O.S.
(1969). Epidemiologic investigation of multiple primary cancer of
the upper alimentary and respiratory tracts. Cancer, 24,
730-739.